Carillion Receives “Outperform” Rating from RBC Capital (CLLN)
Carillion (LON:CLLN)‘s stock had its “outperform” rating reiterated by investment analysts at RBC Capital in a note issued to investors on Thursday, AR Network reports. They currently have a GBX 315 ($5.08) price objective on the stock. RBC Capital’s price target indicates a potential upside of 0.44% from the company’s current price.
CLLN has been the subject of a number of other recent research reports. Analysts at Investec raised their price target on shares of Carillion (LON:CLLN) from GBX 275 ($4.44) to GBX 305 ($4.92) in a research note to investors on Friday, September 27th. They now have a “hold” rating on the stock. Separately, analysts at Cantor Fitzgerald reiterated a “hold” rating on shares of Carillion (LON:CLLN) in a research note to investors on Wednesday, September 25th. They now have a GBX 315 ($5.08) price target on the stock. Finally, analysts at Liberum Capital reiterated a “hold” rating on shares of Carillion (LON:CLLN) in a research note to investors on Tuesday, September 24th. They now have a GBX 280 ($4.52) price target on the stock. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of GBX 304.68 ($4.92).
Shares of Carillion (LON:CLLN) traded down 1.68% on Thursday, hitting GBX 310.40. The stock had a trading volume of 941,639 shares. Carillion has a one year low of GBX 240.00 and a one year high of GBX 334.00. The stock’s 50-day moving average is GBX 299.2 and its 200-day moving average is GBX 280.1. The company’s market cap is £1.335 billion.
Carillion plc is an integrated support services company, with a portfolio of public private partnership projects and construction capabilities.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.